Popular Articles

Yeast 'DNA Damage Sensor' Provides Chemotherapy Resistance Clue
Cancer Research UK scientists have been part of an international collaboration that has revealed the structure of a protein found in simple yeast cells and shown how it flags up damaged DNA for repair. The results of their study are published in Nature*. The finding may provide clues as to how some cancer cells become resistant to certain chemotherapy drugs.
generic viagra online
Battles Loom Over Possible Funding Cuts For MRIs
A Battle looms over possible funding cuts for MRIs amid health care reform efforts.
News of the day
Replacing Both Hips At The Same Time - Is It Safe?
Research published on 1st March 2009 investigates whether "simultaneous bilateral sequential total hip replacement (THR) would increase the rate of mortality and complications compared with unilateral THR", for both low and high risk patients.
Mental Health

FDA Approves Generic Prescription-Only Version Of Plan B Emergency Contraceptive For Women Ages 17 And Under

The U.S. Food and Drug Administration approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under. Plan B was first approved in 1999 for prescription use only for women of all ages. Plan B is manufactured by Duramed Pharmaceuticals Inc., of Cincinnati. In 2006, Plan B was approved for nonprescription use for women ages 18 and older. Plan B remained available as a prescription-only product for women ages 17 and under. Today"s approval allows marketing of a prescription-only generic product for women ages 17 and under. No generic levonorgestrel product for emergency contraception can be approved for nonprescription use in women ages 18 and older until Aug. 24, 2009, when the marketing exclusivity held by Duramed for the nonprescription use expires. The generic levonorgestrel tablets 0.75 mg are made by Watson Laboratories Inc., based in Corona, Calif. Levonorgestrel can prevent pregnancy after unprotected intercourse or a known or suspected contraceptive failure. It is not effective in terminating an existing pregnancy and does not protect against sexually transmitted diseases, including HIV infection. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):